The 70 references in paper O. BERESNEVA N., M. PARASTAYEVA M., A. KUCHER G., G. IVANOVA T., I. KAYUKOV G., A. SMIRNOV V., О. БЕРЕСНЕВА Н., М. ПАРАСТАЕВА М., А. КУЧЕР Г., Г. ИВАНОВА Т., И. КАЮКОВ Г., А. СМИРНОВ В. (2011) “РЕНОПРОТЕКТИВНЫЕ ЭФФЕКТЫ СОЕВОЙ БЕЛКОВОЙ ДИЕТЫ // SOYAMEAL HIGH-PROTEIN DIET RENOPROTECTIVE EFFECTS” / spz:neicon:nefr:y:2011:i:3:p:26-34

1
Наточин ЮВ. Физиология водно-солевого обмена и почки. Наука, СПб., 1993; 23-184
(check this in PDF content)
2
Santo N, Anastassio P, Coppola M et al. Renal hemodynamics, plasma amino acids and hormones after a meat meal in progressive nephron loss. Int J Artif Organs 1991; 14: 161-168
(check this in PDF content)
3
Simon A, Lima P, Almerinda M et al. Renal hemodynamic responses to a chicken or beef meal in normal individuals. Nephrol Dial Transplant 1998; 13 (9): 2261-2264
(check this in PDF content)
4
Soroka N, Silverberg D, Grumland M et al. Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron 1998; 79 (2): 173-180
(check this in PDF content)
5
Chan A, Cheng M, Keil L et al. Functional response of healthy and diseased glomeruli to a large, protein-rich meal. J Clin Invest 1998; 81 (1): 245-254
(check this in PDF content)
6
Kenner C, Evan A, Bromgren P et al. Effect of protein intake on renal function and structure in partially nephrectomized rats. Kidney Int 1985; 27: 739-750
(check this in PDF content)
7
Mandayam S, Mitch W. Dietary protein restriction benefits patients with chronic kidney disease. Nephrology (Carlton) 2006; 11 (1): 53-57
(check this in PDF content)
8
Toeller M, Buyken A. Protein intake – new evidence for its role in diabetic nephropathy. Nephrol Dial Transplant 1998; 13 (8): 1926-1927
(check this in PDF content)
9
Кучер АГ, Есаян АМ, Шишкина ЛИ и др. Влияние нагрузок растительным и животным белком на функциональное состояние почек у здоровых людей. Нефрология 1997; 1 (2): 79-84
(check this in PDF content)
10
Каюков ИГ, Кучер АГ, Есаян АМ. Потребление белка и функциональное состояние почек. Нефрология 2003; 7: 75-78
(check this in PDF content)
11
Береснева ОН, Парастаева ММ, Кучер АГ и др. Влияние содержания белка в диете на прогрессирование экспериментальной хронической почечной недостаточности. Нефрология 2003; 7 (3): 66-70
(check this in PDF content)
12
Dobronravov V, Smirnov A, Parastaeva M et al. Influence of low- and high-soy protein diet on the progression of experimental chronic renal failure. Nephrol Dial Transplant 2005; 20 [ Suppl 5]: 70
(check this in PDF content)
13
Fukui M, Nakamura T, Ebihara I et al. Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis. J Lab Clin Med 1993; 121 (2): 224-234
(check this in PDF content)
14
Bilo J, Schaup G, Blaak E et al. Effects of chronic and acute protein administration on renal function in patients with chronic renal insufficiency. Nephron 1989; 53 (3): 181-187
(check this in PDF content)
15
Кучер АГ, Каюков ИГ, Есаян АМ, Ермаков ЮА. Влияние количества и качества белка в рационе на деятельность почек. Нефрология 2004; 8 (2): 14-34
(check this in PDF content)
16
Molnar M, Szekerene I, Nagy J, Figler M. The effect of low-protein diet supplemented with ketoacids in patients with chronic renal failure. Orv Hetil 2009; 150 (5): 217-224
(check this in PDF content)
17
Mircuscu G, Garneata L, Stancu S et al. Effect of a supplemented hypoproteic diet in chronic kidney disease. J Ren Nutr 2007; 17 (3): 179-188
(check this in PDF content)
18
Goodman W. Medical management of secondary hyperparathyroidism in chronic renal failure. Nephrol Dial Transplant 2003; 18 [Suppl 3]: 2-8
(check this in PDF content)
19
Teplan V, Schuck O, Votrula M et al. Metabolic effects of ketoacid-amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin-randomized controlled trial. Wien Klin Wschr 2001; 113: 661-669
(check this in PDF content)
20
Mitch W. Beneficial responses to modified diets in treating patients with chronic kidney disease. Kidney Int 2005; 94: 133-135
(check this in PDF content)
21
Hara Y, May R, Kelly R, Mitch W. Acidosis, not azotemia stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int 1987; 32: 808-814
(check this in PDF content)
22
Jones M, Kopple J. Valine metabolism in normal and chronic uremic man. Am J Clin Nutr 1978; 31: 1660-1664
(check this in PDF content)
23
Бреннер БМ. Механизмы прогрессирования болезней почек. Нефрология 1999; 3 (4): 23-27
(check this in PDF content)
24
Garcia MC, Torre M, Marina ML et al. Composition of soyabean and related products. Critial Rev Food Sci Nutr 1997; 37 (4): 361-391
(check this in PDF content)
25
Хенли ЕС, Кустер ДМ. Оценка качества белка с помощью скорректированного аминокислотного коэффицинта усвояемости белка. Соевые белки СУПРО в клинической медицине. М.,1997; 5-13
(check this in PDF content)
26
Есаян АМ, Кучер АГ, Каюков ИГ и др. Влияние белковой нагрузки на функциональное состояние почек у больных хроническим гломерулонефритом. Тер Арх 2002; 74 (6): 19-24
(check this in PDF content)
27
Sacks FM, Lichtenstein A, Van Horn L et al. Soy protein, Isoflavones, and Cardiovascular Health. Arterioscler Tromb Vasc Biol 2006; 26: 1689
(check this in PDF content)
28
Adams MR, Golden DL, Frank AA et al. Dietary soy вconglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 2004; 134: 511-516
(check this in PDF content)
29
Wangen K.E, Duncan AM, Merz-Demlow BE et al. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000; 85: 3043-3048
(check this in PDF content)
30
Gallagher J, Satpathy R, Rafferty K et al. The effect of soy protein isolate on bone metabolism. Menopause 2004; 11: 290-298
(check this in PDF content)
31
Arliss RM, Biermann CA. Do soy isoflavones lower cholesterol, inhibit atherosclerosis, and play a role in cancer prevention? Holist Nurs Pract 2002; 16 (5): 40-48
(check this in PDF content)
32
Ranich T, Bhathena S, Velasquez M. Protective effects of dietary phytoestrogens in chronic renal disease. J Ren Nutr 2001; 11 (4): 183-193
(check this in PDF content)
33
Barnes S, Boersma B, Patel R et al. Isoflavonoids and chronic disease: Mechanisms of action: Mini-review. Biofactors (Oxford-Amsterdam) 2000; 12 (1-4): 209-215
(check this in PDF content)
34
Velasquez MT, Bhathena SJ. Dietary phytoestrogens: A possible role in renal disease protection: Editorial review. Am J Kidney Diseases (Philadelphia) 2001; 37 (5): 1056-1068
(check this in PDF content)
35
McCarty M. Is flavones made simple – Genistein,s agonist activity for the beta-type estrogen receptor mediated their health benefits. Med Hypotheses (Harlow) 2006; 66 (6): 1093-1114
(check this in PDF content)
36
Ywang J, Wang J, Morazzoni P at al. The phytoestrogen equal increases nitric oxide availability by inhibiting superoxode production: an antioxidant mechanism for cell-mediated LDL modification. Free Radiac Biol Med 2003; 34: 1271-1282
(check this in PDF content)
37
Fanti P, Asmis R, Stephenson P et al. Positive effect of dietary soy in ESRD patients with systemic inflammation – correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant 2006; 21 (8): 2239-2246
(check this in PDF content)
38
Tovar A, Murguia F, Cruz C et al. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 2002; 132 (9): 2562-2569
(check this in PDF content)
39
Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor-в signaling pathways. Am J Clin Nutr 1998; 68: 1418S-1425S
(check this in PDF content)
40
Pedraza-Chaverri J, Barrera D, Hernandez-Pando K et al. Soy protein diet ameliorates renal nitrotyrosine formation an chronic nephropathy induced by puromycin aminonucleoside. Life Sci. (Oxford) 2004; 74 (8): 987-999
(check this in PDF content)
41
Jackman KA, Woodman OL, Sobey CG. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr Med Chem 2007; 14(26): 2824-2830
(check this in PDF content)
42
Fair D, Ogborn M, Weiler H et al. Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats. J Nutr 2004; 134 (6): 1504-1507
(check this in PDF content)
43
Cahill L, Peng C, Bankovic-Calic N et al. Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring. Br J Nutr 2007; 97 (1): 77-84
(check this in PDF content)
44
Смирнов АВ, Береснева ОН, Парастаева ММ и др. Эффективность влияния малобелковых диет с применением Кетостерила и соевого изолята на течение экспериментальной почечной недостаточности. Нефрология и диализ 2006; 8 (4): 344-349
(check this in PDF content)
45
Williams AJ, Walls J. Metabolic consequences of differing protein diets in experimental renal disease. Eur J Clin Invest 1987; 17: 117–122
(check this in PDF content)
46
Trujillo I, Ramires V, Perez I et al. Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol: Renal Physiol 2005; 288 (1): 108-116
(check this in PDF content)
47
Banz W, Davis J, Peterson R et al. Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats. Obes Res 2004; 12 (12): 1907-1913
(check this in PDF content)
48
Bjorback C, Kahcn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004; 59: 305-331
(check this in PDF content)
49
Яковенко АА, Кучер АГ, Асанина ЮЮ и др. Значение «потенциально уремических токсинов» в развитии недостаточности питания у гемодиализных больных. Нефрология 2008; 12(3): 13-17
(check this in PDF content)
50
Maddox DA, Alavi FK, Silernick EM et al. Protective effects of a soy diet in preventing obesity-linked renal disease. Kidney Int 2002; 61: 94-104
(check this in PDF content)
51
Woodman L, Boujaoude M. The isoflavone daidzein enhances nitric oxide synthesis by decreasing expression of caveolin-1 and increasing expression of calmodulin. FASEB J 2003; 17: 5015
(check this in PDF content)
52
Wu J, Ding X. Hypotensive and physiological effect on angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J Agric Food Chem 2001; 49 (1): 501-506
(check this in PDF content)
53
Maruyama N, Fukuda T, Saka S et al. Molecular and structural analysis of electrophoretic variants of soybean seed storage proteins. Phytochemistry 2003; 64 (3): 701-708
(check this in PDF content)
54
Onishi K, Matova N, Yamada Y et al. Optimal designing of beta-conglycinin to genetically incorporate RPLKPW, a potent anti-hypertensive peptide. Peptides 2004; 25 (1): 37-43
(check this in PDF content)
55
Sirtory C, Even R, Lovati R. Soybean protein diet and plasma cholesterol: from therapy to molecular mechanisms. Ann Acad Sci 1993; 676: 188-201
(check this in PDF content)
56
Tachibana N, Iwaoka Y, Hirotsuka M. в – conglycinin lowers very-low-density lipoprotein – triglyceride levels by increasing adiponectin and insulin sensitivity in rats. Biosci Biotechnol Biohem 2010; 74 (6): 1250-1255
(check this in PDF content)
57
Lovati M, Manzoni C, Corsini A et al. 7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system. J Nutr 1996; 126: 2831-2842
(check this in PDF content)
58
Lovati M, Manzoni C, Gianazza E et al. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr 2000; 130: 2543-2549
(check this in PDF content)
59
Adams M, Golden D, Franke F et al. Dietary soy вconglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 2004; 134: 511-516
(check this in PDF content)
60
Fukui K, Kojima M, Tachibana N et al. Effects of soybean beta-conglycinin on hepatic lipid metabolism and fecal lipid excretion in normal adult rats. Biosci Biotechnol Biochem 2004; 68 (5): 1153-1155
(check this in PDF content)
61
Zaloga GP, Siddiqui RA. Biologically active dietary peptides. Mini Rev Med Chem 2004; 4 (8): 815-821
(check this in PDF content)
62
Kimm MH, Curtis GH, Hardin JA et al. Transport of bovine serum albumin across rat jejunum: role of the enteric nervous system. Am J Physiol 1994; 266 [Gastrointest Liver Physiol 27]: G186-G193
(check this in PDF content)
63
Crowe S, Soda K, Stanisz A et al. Intestinal permeability in allergic rats: nerve involvement in antigen-induced changes. Am J Physiol 1993; 264 [Gastrointest Liver Physiol 27]: G617G623
(check this in PDF content)
64
Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol 1994; 12: 63-84
(check this in PDF content)
65
Harada E, Itoh Y, Sitizyo K et al. Characteristic transport of lactoferrin from the intestinal lumen into the bile via the blood in piglets. Comparative Biochem Physiol 1999; 124A: 321-327
(check this in PDF content)
66
Селиверстова ЕВ, Бурмакин МВ, Шахматова ЕИ и др. Аккумуляция в почке экзогенного белка после его всасывания в кишечнике при развитии экспериментальной почечной недостаточности у крыс. Нефрология 2007; 11 (1): 7-16
(check this in PDF content)
67
Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 1996; 126: 3063-3068
(check this in PDF content)
68
Kitts D, Weiler K. Bioactive proteins and peptides from food are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 2003; 133: 3060-3065
(check this in PDF content)
69
Gianazza E, Eberini I, Arnoldi A et al. A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies. J Nutr 2003; 133: 9-14
(check this in PDF content)
70
Palanisamy N, Viswanathan P, Ravichandran M. Renoprotective and blood pressure-lowering effect of dietary soy protein via protein kinase C beta II inhibition in a rat model of metabolic syndrome. Can J Physiol Pharmacol 2010; 88 (1): 28-37
(check this in PDF content)